Vaccination saves lives

COVID-19 Approved Vaccines and Candidates by Region / Country

main sources:
last content update:
List countries by region ▶ Filter by region ▶ Filter by vaccine type ▶ Filter by vaccine phase ▶
Move the mouse over trial IDs to display the vaccine developer/manufacturer. Click on country or trial IDs for details. Click on to toggle sections display.
εVaccine trials in children

Types of candidate vaccine:

(SHINGRIX) Zoster Vaccine Recombinant, Adjuvanted

Ad26.COV2.S

AdCLD-CoV19

AdimrSC-2f (recombinant RBD +/- Aluminium)

AG0301-COVID19

ARCT-021 

bacTRL-Spike

BECOV2

BNT162 (3 LNP-mRNAs )

ChAdOx1-S - (AZD1222) (Covishield)

ChulaCov19 mRNA vaccine

CIGB-66 (RBD+aluminium hydroxide)  

CIGB-669 (RBD+AgnHB)

COH04S1 (MVA-SARS-2-S)

Coronavirus-Like Particle COVID-19 (CoVLP)

CORVax

COVI-VAC

Covid-19/aAPC vaccine. The Covid-19/aAPC vaccine is prepared by applying lentivirus modification with immune modulatory genes and the viral minigenes to the artificial antigen presenting cells (aAPCs).

COVID19 vaccine

Covigenix VAX-001

CVnCoV 

CVnCoV Vaccine

DelNS1-2019-nCoV-RBD-OPT1 (Intranasal flu-based-RBD )

Dendritic cell vaccine AV-COVID-19. A vaccine consisting of autologous dendritic cells loaded with antigens from SARS-CoV-2, with or without GM-CSF

EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)

FINLAY-FR anti-SARS-CoV-2 Vaccine (RBD + adjuvant)

Gam-COVID-Vac Adeno-based (rAd26-S+rAd5-S)

GLS-5310

GRAd-COV2 (Replication defective Simian Adenovirus (GRAd) encoding S)

GX-19

hAd5-S-Fusion+N-ETSD vaccine

IMP CoVac-1 (SARS-CoV-2 HLA-DR peptides)

Inactivated SARS-CoV-2 vaccine (Vero cell)

INO-4800+electroporation 

KBP-COVID-19 (RBD-based)

LNP-nCoVsaRNA

LV-SMENP-DC vaccine. Dendritic cells are modified with lentivirus vectors expressing Covid-19 minigene SMENP and immune modulatory genes. CTLs are activated by LV-DC presenting Covid-19 specific antigens.

MF59 adjuvanted SARS-CoV-2 Sclamp vaccine

mRNA -1273

MVA-SARS-2-S

MVC-COV1901 (S-2P protein + CpG 1018)

nCov vaccine

QazCovid-in® - COVID-19 inactivated vaccine

RBD (baculovirus production expressed in Sf9 cells) Recombinant SARS-CoV-2 vaccine (Sf9 Cell)

RBD SARS-CoV-2 HBsAg VLP vaccine

Recombinant novel coronavirus vaccine (Adenovirus type 5 vector)

Recombinant SARS-CoV-2 vaccine (CHO Cell)

rVSV-SARS-CoV-2-S Vaccine 

SARS-CoV-2 mRNA vaccine

SARS-CoV-2 rS/Matrix M1-Adjuvant (Full length recombinant SARS CoV-2 glycoprotein nanoparticle vaccine adjuvanted with Matrix M)

SARS-CoV-2 vaccine (inactivated)

SARS-CoV-2 vaccine (vero cells)

SARS-CoV-2 vaccine formulation 1 with adjuvant 1 (S protein (baculovirus production)

SCB-2019 + AS03 or CpG 1018 adjuvant plus Alum adjuvant (Native like Trimeric subunit Spike Protein vaccine)

UB-612 (Multitope peptide based S1-RBD-protein based vaccine)

V591-001 - Measles-vector based (TMV-o38)

VLA2001

VXA-CoV2-1 Ad5 adjuvanted Oral Vaccine platform

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152)

Developers of vaccines:

AnGes + Takara Bio + Osaka University

Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences

Arcturus Therapeutics

AstraZeneca + University of Oxford

Barbara Carlson, University of Oklahoma

Bharat Biotech International Limited

BioNTech + Fosun Pharma ; Jiangsu Provincial Center for Disease Prevention and Control + Pfizer

Cadila Healthcare Ltd.

CanSino Biological Inc./Beijing Institute of Biotechnology

Clover Biopharmaceuticals Inc./GSK/Dynavax

COVAXX + United Biomedical Inc

CSL Ltd. + Seqirus + University of Queensland

CureVac AG

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"

Gamaleya Research Institute ; Health Ministry of the Russian Federation

Genexine Consortium

Imperial College London

Inovio Pharmaceuticals + International Vaccine Institute

Institute of Medical Biology + Chinese Academy of Medical Sciences

Instituto Finlay de Vacunas

Janssen Pharmaceutical

Jiangsu Provincial Center for Disease Prevention and Control 

Kentucky Bioprocessing Inc.

Medicago Inc.

Medigen Vaccine Biologics + Dynavax + National Institute of Allergy and Infectious Diseases (NIAID)

Merck & Co. + Themis + Sharp & Dohme + Institute Pasteur + Univeristy of Pittsburgh

Moderna + National Institute of Allergy and Infectious Diseases (NIAID)

Novavax

ReiThera + Leukocare + Univercells

Research Institute for Biological Safety Problems, Rep of Kazakhstan

Sanofi Pasteur + GSK

Serum Institute of India + Accelagen Pty

Shenzhen Geno-Immune Medical Institute

Shenzhen Kangtai Biological Products Co., Ltd.

Shulan (Hangzhou) Hospital + Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region

Sinopharm + Beijing Institute of Biological Products

Sinopharm + Wuhan Institute of Biological Products

Sinovac Research and Development Co., Ltd

University Hospital Tuebingen

University of Munich (Ludwig-Maximilians)

Vaxart

Vaxine Pty Ltd. + Medytox

West China Hospital + Sichuan University